Drug Shortage Report for ACT AMLODIPINE

Last updated on 2017-09-19 History
Report ID 3348
Drug Identification Number 02297477
Brand name ACT AMLODIPINE
Common or Proper name AMLODIPINE
Company Name TEVA CANADA LIMITED
Active Ingredient(s) AMLODIPINE
Strength(s) 2.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-17
Estimated end date 2017-07-31
Actual end date 2017-09-01
Shortage status Resolved
Updated date 2017-09-19
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2017-09-19 French Compare
v4 2017-09-19 English Compare
v3 2017-03-18 English Compare
v2 2017-03-17 French Compare
v1 2017-03-17 English Compare